1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits to the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. GLOBAL DRUG DELIVERY MARKET BY TYPE
5.1. Introduction
5.2. Inhalation Drug Delivery
5.2.1. Market Opportunities and Trends
5.2.2. Growth Prospects
5.2.3. Geographic Lucrativeness
5.3. Injectable Drug Delivery
5.3.1. Market Opportunities and Trends
5.3.2. Growth Prospects
5.3.3. Geographic Lucrativeness
5.4. Nasal Drug Delivery
5.4.1. Market Opportunities and Trends
5.4.2. Growth Prospects
5.4.3. Geographic Lucrativeness
5.5. Oral Drug Delivery
5.5.1. Market Opportunities and Trends
5.5.2. Growth Prospects
5.5.3. Geographic Lucrativeness
5.6. Transdermal Drug Delivery
5.6.1. Market Opportunities and Trends
5.6.2. Growth Prospects
5.6.3. Geographic Lucrativeness
6. GLOBAL DRUG DELIVERY MARKET BY TECHNIQUE
6.1. Introduction
6.2. Needle-free injectors
6.2.1. Market Opportunities and Trends
6.2.2. Growth Prospects
6.2.3. Geographic Lucrativeness
6.3. Drug delivery patches
6.3.1. Market Opportunities and Trends
6.3.2. Growth Prospects
6.3.3. Geographic Lucrativeness
6.4. Autoinjectors
6.4.1. Market Opportunities and Trends
6.4.2. Growth Prospects
6.4.3. Geographic Lucrativeness
6.5. Others
6.5.1. Market Opportunities and Trends
6.5.2. Growth Prospects
6.5.3. Geographic Lucrativeness
7. GLOBAL DRUG DELIVERY MARKET BY APPLICATION
7.1. Introduction
7.2. Cancer treatment
7.2.1. Market Opportunities and Trends
7.2.2. Growth Prospects
7.2.3. Geographic Lucrativeness
7.3. Infectious diseases treatment
7.3.1. Market Opportunities and Trends
7.3.2. Growth Prospects
7.3.3. Geographic Lucrativeness
7.4. Others
7.4.1. Market Opportunities and Trends
7.4.2. Growth Prospects
7.4.3. Geographic Lucrativeness
8. GLOBAL DRUG DELIVERY MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Type
8.2.2. By Technique
8.2.3. By Application
8.2.4. By Country
8.2.4.1. USA
8.2.4.1.1. Market Opportunities and Trends
8.2.4.1.2. Growth Prospects
8.2.4.2. Canada
8.2.4.2.1. Market Opportunities and Trends
8.2.4.2.2. Growth Prospects
8.2.4.3. Mexico
8.2.4.3.1. Market Opportunities and Trends
8.2.4.3.2. Growth Prospects
8.3. South America
8.3.1. By Type
8.3.2. By Technique
8.3.3. By Application
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.1.1. Market Opportunities and Trends
8.3.4.1.2. Growth Prospects
8.3.4.2. Argentina
8.3.4.2.1. Market Opportunities and Trends
8.3.4.2.2. Growth Prospects
8.3.4.3. Others
8.3.4.3.1. Market Opportunities and Trends
8.3.4.3.2. Growth Prospects
8.4. Europe
8.4.1. By Type
8.4.2. By Technique
8.4.3. By Application
8.4.4. By Country
8.4.4.1. Germany
8.4.4.1.1. Market Opportunities and Trends
8.4.4.1.2. Growth Prospects
8.4.4.2. France
8.4.4.2.1. Market Opportunities and Trends
8.4.4.2.2. Growth Prospects
8.4.4.3. United Kingdom
8.4.4.3.1. Market Opportunities and Trends
8.4.4.3.2. Growth Prospects
8.4.4.4. Spain
8.4.4.4.1. Market Opportunities and Trends
8.4.4.4.2. Growth Prospects
8.4.4.5. Others
8.4.4.5.1. Market Opportunities and Trends
8.4.4.5.2. Growth Prospects
8.5. Middle East and Africa
8.5.1. By Type
8.5.2. By Technique
8.5.3. By Application
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.1.1. Market Opportunities and Trends
8.5.4.1.2. Growth Prospects
8.5.4.2. UAE
8.5.4.2.1. Market Opportunities and Trends
8.5.4.2.2. Growth Prospects
8.5.4.3. Israel
8.5.4.3.1. Market Opportunities and Trends
8.5.4.3.2. Growth Prospects
8.5.4.4. Others
8.5.4.4.1. Market Opportunities and Trends
8.5.4.4.2. Growth Prospects
8.6. Asia Pacific
8.6.1. By Type
8.6.2. By Technique
8.6.3. By Application
8.6.4. By Country
8.6.4.1. China
8.6.4.1.1. Market Opportunities and Trends
8.6.4.1.2. Growth Prospects
8.6.4.2. India
8.6.4.2.1. Market Opportunities and Trends
8.6.4.2.2. Growth Prospects
8.6.4.3. South Korea
8.6.4.3.1. Market Opportunities and Trends
8.6.4.3.2. Growth Prospects
8.6.4.4. Taiwan
8.6.4.4.1. Market Opportunities and Trends
8.6.4.4.2. Growth Prospects
8.6.4.5. Thailand
8.6.4.5.1. Market Opportunities and Trends
8.6.4.5.2. Growth Prospects
8.6.4.6. Indonesia
8.6.4.6.1. Market Opportunities and Trends
8.6.4.6.2. Growth Prospects
8.6.4.7. Japan
8.6.4.7.1. Market Opportunities and Trends
8.6.4.7.2. Growth Prospects
8.6.4.8. Others
8.6.4.8.1. Market Opportunities and Trends
8.6.4.8.2. Growth Prospects
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Pfizer
10.2. Insulet Corporation
10.3. West Pharmaceutical Services, Inc.
10.4. Enable Injections
10.5. Mersana Therapeutics
10.6. Becton, Dickinson and Company
10.7. Recipharm AB
10.8. Medtronic
10.9. Boston Scientific Corporation